PCP: Difference between revisions
>Tracer |
>Golferjoe99 |
||
Line 111: | Line 111: | ||
{{#ask: [[Category:PCP]][[Category:Experience]]|format=ul|Columns=1}} | {{#ask: [[Category:PCP]][[Category:Experience]]|format=ul|Columns=1}} | ||
Additional experience reports can be found here: | Additional experience reports can be found here: | ||
*[https://www.erowid.org/experiences/subs/exp_PCP.shtml Erowid Experience Vaults: PCP] | *[https://www.erowid.org/experiences/subs/exp_PCP.shtml Erowid Experience Vaults: PCP] | ||
Line 126: | Line 127: | ||
*Users should avoid taking the drug multiple days in a row or becoming addicted to it as this increases the risk of severe adverse effects. | *Users should avoid taking the drug multiple days in a row or becoming addicted to it as this increases the risk of severe adverse effects. | ||
*The recommended dosage range should not be exceeded as high doses can trigger adverse effects. | *The recommended dosage range should not be exceeded as high doses can trigger adverse effects. | ||
*Users should start with extremely low doses and work their way up as slowly as possible. [[Volumetric liquid dosing|Volumetric liquid dosing]] should preferably be used due to the drug's potency; most standard milligram scales cannot accurately weigh out doses below 10-15mg. | *Users should start with extremely low doses and work their way up as slowly as possible. [[Volumetric liquid dosing|Volumetric liquid dosing]] should preferably be used due to the drug's potency; most standard milligram scales cannot accurately weigh out doses below 10-15mg. | ||
*[[Compulsive redosing]] before one has fully sobered up is not recommended and can result in too high of a dose. | *[[Compulsive redosing]] before one has fully sobered up is not recommended and can result in too high of a dose. | ||
Due to the risk of psychosis, it is not recommended to combine this drug with other substances, especially [[stimulant|stimulants]], [[psychedelic|psychedelics]], or other [[dissociative|dissociatives]] like [[MXE]] and [[DXM]]. [https://www.google.com/ Independent research] should always be done to ensure that a combination of two or more substances is safe before consumption. | Due to the risk of psychosis, it is not recommended to combine this drug with other substances, especially [[stimulant|stimulants]], [[psychedelic|psychedelics]], or other [[dissociative|dissociatives]] like [[MXE]] and [[DXM]]. [https://www.google.com/ Independent research] should always be done to ensure that a combination of two or more substances is safe before consumption. | ||
Line 144: | Line 145: | ||
In terms of its long-term health effects when used repeatedly and excessively for extended periods of time, PCP seems to exhibit almost identical bladder and urinary tract problems to those produced by [[ketamine]]. | In terms of its long-term health effects when used repeatedly and excessively for extended periods of time, PCP seems to exhibit almost identical bladder and urinary tract problems to those produced by [[ketamine]]. | ||
*'''Urinary frequency''' - Urinary frequency is the need to empty the bladder every few minutes. | *'''Urinary frequency''' - Urinary frequency is the need to empty the bladder every few minutes. | ||
*'''Urinary urgency''' - This can be described as a sudden, compelling need to urinate. | *'''Urinary urgency''' - This can be described as a sudden, compelling need to urinate. | ||
*'''Urinary pressure''' - This is experienced as a constant sensation of fullness in the bladder that is unrelieved by urination. | *'''Urinary pressure''' - This is experienced as a constant sensation of fullness in the bladder that is unrelieved by urination. | ||
Line 180: | Line 181: | ||
*'''Germany:''' PCP is controlled under BtMG Anlage I, making it illegal to manufacture, import, possess, sell, or transfer it without a license.<ref>http://www.gesetze-im-internet.de/btmg_1981/anlage_i.html</ref> | *'''Germany:''' PCP is controlled under BtMG Anlage I, making it illegal to manufacture, import, possess, sell, or transfer it without a license.<ref>http://www.gesetze-im-internet.de/btmg_1981/anlage_i.html</ref> | ||
*'''New Zealand''' - PCP is Schedule I (class A) in New Zealand.{{citation needed}} | *'''New Zealand''' - PCP is Schedule I (class A) in New Zealand.{{citation needed}} | ||
*'''Poland''' - PCP is | *'''Poland''' - PCP is listed under "Wykaz środków odurzających i substancji psychotropowych[" (II-P group) in Poland, and is illegal to posses, sell and manufacture.<ref>https://pl.wikipedia.org/wiki/Wykaz_%C5%9Brodk%C3%B3w_odurzaj%C4%85cych_i_substancji_psychotropowych#Grupa_II-P</ref> | ||
*'''Portugal''' - Effective July 2001, personal use of PCP was decriminalized by Law 30/2000. Possession of less than 100 mg is not regarded as a criminal offense, although the substance is liable to be seized and the possessor can be referred to mandatory treatment. Sale or possession of quantities greater than the personal possession limit are criminal offenses punishable by jail time.{{citation needed}} | *'''Portugal''' - Effective July 2001, personal use of PCP was decriminalized by Law 30/2000. Possession of less than 100 mg is not regarded as a criminal offense, although the substance is liable to be seized and the possessor can be referred to mandatory treatment. Sale or possession of quantities greater than the personal possession limit are criminal offenses punishable by jail time.{{citation needed}} | ||
*'''Switzerland:''' PCP is a controlled substance specifically named under Verzeichnis A. Medicinal use is permitted.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref> | *'''Switzerland:''' PCP is a controlled substance specifically named under Verzeichnis A. Medicinal use is permitted.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref> | ||
Line 187: | Line 188: | ||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
**[[Volumetric dosing]] | **[[Volumetric dosing]] | ||
Line 198: | Line 200: | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/Phencyclidine PCP (Wikipedia)] | *[https://en.wikipedia.org/wiki/Phencyclidine PCP (Wikipedia)] | ||
*[https://www.erowid.org/chemicals/pcp/ PCP (Erowid Vault)] | *[https://www.erowid.org/chemicals/pcp/ PCP (Erowid Vault)] | ||
Line 203: | Line 206: | ||
===Forums=== | ===Forums=== | ||
*[http://www.bluelight.org/vb/threads/316953-The-Big-amp-Dandy-PCP-Thread PCP (Bluelight)] | *[http://www.bluelight.org/vb/threads/316953-The-Big-amp-Dandy-PCP-Thread PCP (Bluelight)] | ||
==Literature== | ==Literature== | ||
* Morris, H., & Wallach, J. (2014). From PCP to MXE: A comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis, 6(7–8), 614–632. https://doi.org/10.1002/dta.1620 | |||
*Morris, H., & Wallach, J. (2014). From PCP to MXE: A comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis, 6(7–8), 614–632. https://doi.org/10.1002/dta.1620 | |||
==References== | ==References== |